ResMed Inc.
Michael J. Farrell (Chairman and CEO) reports RMD insider transactions
AI-generated summary
Chairman and CEO, Director Michael J. Farrell received 48,136 shares as a grant on November 19, 2026. On the same date, 28,180.245 shares were disposed of for a tax withholding at an average price of $236.88, valued at $6,675,336.44. Following these transactions, the insider directly held 491,729 shares of ResMed Common Stock.
Key facts
- Insider
- Michael J. Farrell · Chairman and CEO, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | A · grantFootnotes F1 | +48,136 | $0.00 | $0.00 | 519,910 | Direct |
| Nov 19, 2026 | F · tax withholdingFootnotes F2 | −28,180.245 | $236.88 | $6,675,336.44 | 491,729 | Direct |
Footnotes
- F1 Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on November 19, 2026, when the compensation and leadership development committee certified that the performance metrics were met for this portion of the grant.
- F2 Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on 11/16/2023.
More RMD filings
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
- 4
Filed Nov 20, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.